Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Available axes
Side-by-side release fields
Each side retains its own unit and denominator. Entity evidence and containing-label observations do not imply a product score or a head-to-head efficacy finding.
A1: Not available in this release.. Identity: Not available in this release.; quantity disclosure: Not available in this release.; potency: Not available in this release.. No exact DSLD label record was resolved for this named canary in the release snapshot; organism list unavailable.
Axis 2 · evidence
A2: no applicable score. Evidence amount: Not available in this release.; PubMed RCT records: undefined: Not available in this release.; direction balance: The direction of the study results has not been extracted.
Axis 3 · measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4 · observed review panel
undefined: no review panel matched this side.
Preference-dependent summary and price
GIS: no aggregate entity score. Price: undefined: no observation in this release. Observed: undefined: observation date unavailable.
Ivitskiy, I. (2026). Visbiome vs Alfasigma USA VSL#3 Capsules. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/vs/visbiome-vs-vsl-3-capsules/
Visbiome prints strain designations for 0 of 0 observed organisms (undefined: no observations), compared with 0 of 8 (0.0%) for Alfasigma USA VSL#3 Capsules. Window: NIH DSLD snapshot Sep 2026.
Visbiome states through_expiry on 0 of 0 observed labels (undefined: no observations), compared with 0 of 1 (0.0%) for Alfasigma USA VSL#3 Capsules. Window: NIH DSLD snapshot Sep 2026.
Visbiome: Not yet queried in this release. Alfasigma USA VSL#3 Capsules: 1334 PubMed record matches across 7 printed-entity queries (query dates: 2026-09-15). Records may overlap across these ingredient queries; this is not a product trial count.
Not yet queried in this release. / Not available in this release. PubMed records in the union of both compared entries · NIH DSLD snapshot Sep 2026 · comparison.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
0 of 2 compared entries have a numeric price: Visbiome, No numeric price observation is available in this release.; Alfasigma USA VSL#3 Capsules, No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.